The latest version of Nervecentre Software’s electronic patient record (EPR) has been launched in London.

In a brochure, the supplier claims the newest version of its EPR “combines 21st Century mobile technology with intuitive, clinically-led design” and is the “UK’s first truly mobile EPR”.

Nervercentre CEO and founder, Paul Volkaerts, said: “Mobile EPR isn’t a PC on wheels.

“It’s not even an iPad or a bulky tablet device that gets left in the office.

“A mobile EPR is with the clinician all the time – it’s in their pocket, ready to be used without intruding on, or breaking away from, the patient consultation.

“The tools of EPR must be part of the clinician’s uniform.”

Attendees of the launch at the Science Museum on 20 June were given a peek into version five of Nervecentre’s “next-generation” EPR which is a step up from it’s original clinical flow system.

Speaking to the audience at the event, Volkaerts said the challenge was for the NHS to make sure it was keeping up with technology.

He said: “The challenge of the NHS is that is has adapted so significantly over the last 10 to 15 years, technology needs to keep pace with that.”

The audience was also shown a number of demonstrations from Volkaerts as well as director of clinical operations, Debbie Guy, and clinical lead, Vicki Kaluza to show what the company had spent the last 18 months developing.

This included showing their brand new features such as outpatient scheduling, care plans as well as mobile order comms and mobile fluid balance.

In a segment on looking towards the future, Volkaerts teased a number of features his team was working on.

This included introducing e-prescribing, which Nervecentre hopes will be integrated with its EPR by 2020.

Mike Barnes, technical operations manager at Nervecentre, gave a sneak peak into the software company’s patient-facing app, which allows users to check themselves into A&E.

According to Digital Health’s Intelligence, Nervecentre has been deployed in more than 40 NHS organisations.

This includes Maidstone and Tunbridge Wells NHS Trust, which signed a five-year-deal with Nervecentre in 2014.